Sialoadenitis Management Guidelines

Initial Assessment and Risk Stratification

Airway compromise, particularly with submandibular gland involvement, can cause acute hypoxemic respiratory failure, and immediate assessment is crucial 1
Underlying systemic conditions, such as Sjögren's syndrome, should be considered in patients with bilateral involvement, chronic/recurrent episodes, or associated sicca symptoms, as approximately 10% of patients with clinically significant aqueous deficient dry eye have underlying primary Sjögren's syndrome 2, 3

Aggressive intravenous hydration is essential, especially in elderly or dehydrated patients, to prevent complications 1
Sialagogues, such as sugar-free acidic candies, lozenges, or chewing gum, can stimulate saliva production and aid in management 4
Warm compresses and gland massage (with caution in elderly patients and those with suspected carotid stenosis) can help promote salivary flow 4
A very low threshold for airway intervention should be maintained, as 13 of 15 patients in one series required deferred extubation, early reintubation, or emergent tracheostomy 4, 5
Neurologic complications from inflammatory compression, such as brachial plexopathy, facial nerve palsy, or Horner syndrome, should be monitored 1

The American College of Rheumatology recommends considering Sjögren's syndrome in non-elderly women with rapid onset or severe intrinsic tear-production deficiency 3
Artificial tears and saliva substitutes can help manage sicca symptoms in patients with Sjögren's syndrome 7
Systemic immunomodulatory therapy should be restricted to patients with active systemic disease requiring organ-specific intervention, and rheumatology referral is mandatory given the systemic autoimmune nature and risk of life-threatening vasculitic or lymphoproliferative disorders 2, 3, 6
Regular monitoring every 6-12 months for asymptomatic patients with isolated anti-Ro/SS-A positivity is recommended, and increased surveillance for MALT lymphoma development (5-10% risk) is necessary, particularly in patients with decreased C4 levels 3, 6, 7